GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (OTCPK:AVHHL) » Definitions » PB Ratio
中文

AVITA Medical (AVITA Medical) PB Ratio : 5.50 (As of Apr. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is AVITA Medical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), AVITA Medical's share price is $2.10. AVITA Medical's Book Value per Share for the quarter that ended in Dec. 2023 was $0.38. Hence, AVITA Medical's PB Ratio of today is 5.50.

The historical rank and industry rank for AVITA Medical's PB Ratio or its related term are showing as below:

AVHHL' s PB Ratio Range Over the Past 10 Years
Min: 1.17   Med: 4.54   Max: 264.63
Current: 4.7

During the past 13 years, AVITA Medical's highest PB Ratio was 264.63. The lowest was 1.17. And the median was 4.54.

AVHHL's PB Ratio is ranked worse than
75.13% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 2.21 vs AVHHL: 4.70

During the past 12 months, AVITA Medical's average Book Value Per Share Growth Rate was -43.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -17.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 73.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 35.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of AVITA Medical was 212.10% per year. The lowest was -54.90% per year. And the median was -20.05% per year.

Back to Basics: PB Ratio


AVITA Medical PB Ratio Historical Data

The historical data trend for AVITA Medical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical PB Ratio Chart

AVITA Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 141.78 0.59 2.48 1.86 6.81

AVITA Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 4.08 5.56 5.42 6.81

Competitive Comparison of AVITA Medical's PB Ratio

For the Medical Devices subindustry, AVITA Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's PB Ratio distribution charts can be found below:

* The bar in red indicates where AVITA Medical's PB Ratio falls into.



AVITA Medical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

AVITA Medical's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=2.10/0.382
=5.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


AVITA Medical  (OTCPK:AVHHL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


AVITA Medical PB Ratio Related Terms

Thank you for viewing the detailed overview of AVITA Medical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AVITA Medical (AVITA Medical) Business Description

Traded in Other Exchanges
Address
28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.